Mikhail V. Kulak

948 total citations
31 papers, 705 citations indexed

About

Mikhail V. Kulak is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mikhail V. Kulak has authored 31 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Mikhail V. Kulak's work include Ubiquitin and proteasome pathways (6 papers), Virology and Viral Diseases (5 papers) and Cancer Cells and Metastasis (5 papers). Mikhail V. Kulak is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Virology and Viral Diseases (5 papers) and Cancer Cells and Metastasis (5 papers). Mikhail V. Kulak collaborates with scholars based in United States, Russia and Belarus. Mikhail V. Kulak's co-authors include Ronald J. Weigel, George W. Woodfield, Philip M. Spanheimer, Frederick E. Domann, Maria V. Bogachek, Anthony R. Cyr, James P. De Andrade, Jung M. Park, Alena Atrasheuskaya and G. M. Ignatyev and has published in prestigious journals such as PLoS ONE, Cancer Cell and Cancer Research.

In The Last Decade

Mikhail V. Kulak

30 papers receiving 694 citations

Peers

Countries citing papers authored by Mikhail V. Kulak

Since Specialization

Citations

This map shows the geographic impact of Mikhail V. Kulak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail V. Kulak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail V. Kulak more than expected).

Fields of papers citing papers by Mikhail V. Kulak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail V. Kulak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail V. Kulak. The network helps show where Mikhail V. Kulak may publish in the future.

Co-authorship network of co-authors of Mikhail V. Kulak

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail V. Kulak. A scholar is included among the top collaborators of Mikhail V. Kulak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail V. Kulak. Mikhail V. Kulak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis 2021 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Anna C. Beck, (unknown), (unknown), Mikhail V. Kulak, Ronald J. Weigel	26
2	AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer 2021 ·Molecular Cancer Research ·Anna C. Beck, Edward H. Cho, (unknown), Lily Paemka, Tiandao Li, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mikhail V. Kulak, Ronald J. Weigel	17
3	AP-2γ Is Required for Maintenance of Multipotent Mammary Stem Cells 2020 ·Stem Cell Reports ·(unknown), Edward H. Cho, (unknown), (unknown), Nicholas Borcherding, (unknown), (unknown), (unknown), (unknown), (unknown), Mikhail V. Kulak, Trevor Williams, Weizhou Zhang, Ronald J. Weigel	6
4	Identification of a small heat shock protein gene from pistachio. 2019 ·Michal Koc, Mikhail V. Kulak, (unknown), (unknown)	1
5	A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer 2019 ·Molecular Cancer Research ·(unknown), (unknown), (unknown), (unknown), Anna C. Beck, Nicholas Borcherding, Tiandao Li, (unknown), (unknown), Weizhou Zhang, Terry A. Braun, Bartley Brown, Vimla Band, Hamid Band, Mikhail V. Kulak, Ronald J. Weigel	13
6	TFAP2C regulates carbonic anhydrase XII in human breast cancer 2019 ·Oncogene ·(unknown), (unknown), (unknown), (unknown), (unknown), Ronald J. Weigel, Mikhail V. Kulak	21
7	A novel HER2 gene body enhancer contributes to HER2 expression 2017 ·Oncogene ·(unknown), Mikhail V. Kulak, Nicholas Borcherding, Peterson Kariuki Maina, (unknown), Ronald J. Weigel, Hank H. Qi	39
8	EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib 2016 ·Molecular Cancer Therapeutics ·James P. De Andrade, Jung M. Park, (unknown), George W. Woodfield, Mikhail V. Kulak, (unknown), (unknown), (unknown), Philip M. Spanheimer, Ronald J. Weigel	33
9	Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas 2016 ·Stem Cell Reports ·Maria V. Bogachek, Jung M. Park, James P. De Andrade, (unknown), Mikhail V. Kulak, (unknown), (unknown), (unknown), Ronald J. Weigel	54
10	Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer 2015 ·Annals of Surgical Oncology ·Philip M. Spanheimer, (unknown), James P. De Andrade, Mikhail V. Kulak, Jennifer C. Carr, George W. Woodfield, Sonia L. Sugg, Ronald J. Weigel	19
11	Inhibition of RET Increases the Efficacy of Antiestrogen and Is a Novel Treatment Strategy for Luminal Breast Cancer 2014 ·Clinical Cancer Research ·Philip M. Spanheimer, Jung Min Park, Ryan W. Askeland, Mikhail V. Kulak, George W. Woodfield, James P. De Andrade, Anthony R. Cyr, Sonia L. Sugg, Alexandra Thomas, Ronald J. Weigel	33
12	Hypoxia perturbs aryl hydrocarbon receptor signaling and CYP1A1 expression induced by PCB 126 in human skin and liver-derived cell lines 2013 ·Toxicology and Applied Pharmacology ·Sabine U. Vorrink, Paul Severson, Mikhail V. Kulak, Bernard W. Futscher, Frederick E. Domann	64
13	Human Melanoma Cells Over-Express Extracellular Matrix 1 (ECM1) Which Is Regulated by TFAP2C 2013 ·PLoS ONE ·Geeta Lal, (unknown), Mikhail V. Kulak, George W. Woodfield, Thomas Bair, Frederick E. Domann, Ronald J. Weigel	18
14	High TFAP2C/low CD44 expression is associated with an increased rate of pathologic complete response following neoadjuvant chemotherapy in breast cancer 2013 ·Journal of Surgical Research ·Philip M. Spanheimer, Ryan W. Askeland, Mikhail V. Kulak, Tong Wu, Ronald J. Weigel	11
15	Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer 2012 ·Oncogene ·Mikhail V. Kulak, Anthony R. Cyr, George W. Woodfield, Maria V. Bogachek, Philip M. Spanheimer, Tiandao Li, David H. Price, Frederick E. Domann, Ronald J. Weigel	51
16	Expression of the RET Proto-oncogene Is Regulated by TFAP2C in Breast Cancer Independent of the Estrogen Receptor 2012 ·Annals of Surgical Oncology ·Philip M. Spanheimer, George W. Woodfield, Anthony R. Cyr, Mikhail V. Kulak, (unknown), Thomas Bair, Ronald J. Weigel	23
17	Genetic and biological characterization of avian influenza H5N1 viruses isolated from wild birds and poultry in Western Siberia 2010 ·Archives of Virology ·Kirill Sharshov, (unknown), Roman V. Uzhachenko, (unknown), Anna V. Zaykovskaya, Olga Kurskaya, Philipp A. Ilinykh, (unknown), Mikhail V. Kulak, А. Yu. Alekseev, (unknown), А. М. Шестопалов, (unknown)	23
18	Nomenclatural changes in Liparis-complex [Malaxidinae, Epidendroideae] 2008 ·Acta Societatis Botanicorum Poloniae ·Dariusz L. Szlachetko, (unknown), Mikhail V. Kulak	4
19	Measles cases in highly vaccinated population of Novosibirsk, Russia, 2000–2005 2008 ·Vaccine ·Alena Atrasheuskaya, Mikhail V. Kulak, (unknown), Steven A. Rubin, G. M. Ignatyev	36
20	Mumps vaccine failure investigation in Novosibirsk, Russia, 2002–2004 2007 ·Clinical Microbiology and Infection ·Alena Atrasheuskaya, Mikhail V. Kulak, Steven A. Rubin, G. M. Ignatyev	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact